Selank Dosing Schedule: Titration, Timing, and Missed Doses

Selank at a glance:

• Drug class: Neuropeptide / nootropic
• Route: intranasal or subcutaneous (research and ex-US clinical use)
• Typical frequency: varies
• Half-life: typically minutes systemically; intranasal formulations target CNS

The wrong Selank dose — too high, too low, or escalated too quickly — is the most common reason people stop the drug. FDA-approved analogs do not exist.

Standard Dosing Schedule for Selank

FDA-approved analogs do not exist. Russian or Eastern European labels exist for some agents.

The typical schedule for Selank is varies via intranasal or subcutaneous (research and ex-US clinical use). Half-life of typically minutes systemically; intranasal formulations target CNS explains why this schedule works — the drug stays active long enough to support that interval.

Titration: Why Starting Low Matters

For this class of compound, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms .

A typical titration plan for Selank holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.

Missed Doses

If a dose of Selank is missed: for daily schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (typically minutes systemically; intranasal formulations target CNS) and the specific product label. Never double up to make up for a missed dose.

Dose Adjustments

Dose adjustments may be needed for the following:

• Significant weight loss or weight gain
• Side-effect intolerance at the current step
• Changes in renal or hepatic function
• Drug interactions (particularly relevant for any concurrent medications)

We cover the side-effect side of dose decisions in Selank side effects and the cost angle of dose escalation in Selank cost.

What the Trials Used

Published clinical data on this compound is limited. Most reported dosing comes from observational or non-clinical sources.

That data drives the labeled dosing range, which is what physicians prescribe by.

Special Populations

The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.

For Selank: the standard contraindications for this drug class apply.

Bottom Line

Most Selank dose questions resolve in a 5-minute conversation with a clinician. Don't carry them around — get them answered.

Frequently Asked Questions

Related Reading

• Selank Explained: How It Works and Who It's For
• Selank Side Effects Decoded: What's Normal vs. What Isn't
• Real Selank Results: What 6 and 12 Months Actually Look Like
• Selank Cost in 2026: What You'll Actually Pay (Real Numbers)
• Is Noopept Right for You? An Evidence-Based Breakdown
• Noopept Side Effects: 7 Things to Watch For (and How to Manage Them)

Sources

• Kozlovskaya MM et al. Selank and Short Peptides of the Glyprolines Family — Anxiolytic and Nootropic Activity. Eksp Klin Farmakol 2003;66:43.
• Muresanu DF et al. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled Trial. Stroke 2016;47:151.

This page is informational only and is not medical advice. We do not provide guidance for self-administration of compounds that are not FDA-approved.